Perceived stress is associated with impaired t-cell response to HPV16 in women with cervical dysplasia

Annals of Behavioral Medicine

Volumn 35, Issue 1, 2008, Pages 87-96

  Fang, Carolyn Y ^a   Miller, Suzanne M ^a   Bovbjerg, Dana H ^b   Bergman, Cynthia ^a   Edelson, Mitchell I ^c   Rosenblum, Norman G ^d   Bove, Betsy A ^a   Godwin, Andrew K ^a   Campbell, Donald E ^e,f   Douglas, Steven D ^e,f  

^a FOX CHASE CANCER CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c ABINGTON MEMORIAL HOSPITAL   (United States)

^d THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cervical Dysplasia; Human Papillomavirus; Stress; T cell Proliferative Response

Indexed keywords

ADULT; ARTICLE; BLOOD SAMPLING; CELLULAR IMMUNITY; COLPOSCOPY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEALTH BEHAVIOR; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; LIFE STRESS; LOGISTIC REGRESSION ANALYSIS; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PERCEPTION; T LYMPHOCYTE; UTERINE CERVIX DYSPLASIA; VIRUS INFECTION; VIRUS TYPING;

ADULT; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CROSS-SECTIONAL STUDIES; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL; T-LYMPHOCYTES; UTERINE CERVICAL DYSPLASIA;

EID: 42549139846     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12160-007-9007-6     Document Type: Article

References (55)

1. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 1992; 327: 1272-1278.
2. Stoler MH. A brief synopsis of the role of human papillomaviruses in cervical carcinogenesis. Am J Obstet Gynecol. 1996; 175: 1091-1098.
3. Wolf JK, Franco EL, Arbeit JM, et al. Innovations in understanding the biology of cervical cancer. Cancer. 2003; 98: 2064-2069.
4. Franco EL, Schlecht NF, Saslow D. The epidemiology of cervical cancer. Cancer J. 2003; 9: 348-359.
5. Mitchell MF, Tortolero-Luna G, Wright T, et al. Cervical human papillomavirus infection and intraepithelial neoplasia: a review. J Natl Cancer Inst Monographs. 1996; 21: 17-25.
6. Schoell WMJ, Janicek MF, Mirhashemi R. Epidemiology and biology of cervical cancer. Sem Surg Oncol. 1999; 16: 203-211.
7. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. J Am Med Assoc. 2007; 297: 813-819.
8. Castle PE, Wacholder S, Lorincz AT, et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst. 2002; 94: 1406-1414.
9. Schiffman MH, Castle P. Epidemiologic studies of a necessary causal risk factor: Human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst. 2003; 95: E2.
10. Castle PE, Solomon D, Schiffman M, Wheeler CM. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J Natl Cancer Inst. 2005; 97: 1066-1071.
11. Vermund SH, Kelley KF, Klein RS, et al. High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol. 1991; 165: 392-400.
12. Maiman M. Management of cervical neoplasia in human immunodeficiency virus-infected women. J Natl Cancer Inst Monographs. 1998; 1998: 43-49.
13. Hawes SE, Critchlow CW, Sow PS, et al. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2. J Natl Cancer Inst. 2006; 98: 100-109.
14. Kadish AS, Ho GYF, Burk RD, et al. Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: Outcome of HPV infection and associated neoplasia. J Natl Cancer Inst. 1997; 89: 1285-1293.
15. Kadish AS, Timmins P, Wang Y, et al. Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide. Cancer Epidemiol Biomark Prev. 2002; 11: 483-488.
16. Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med. 2002; 347: 1645-1651.
17. Washam C. Two HPV vaccines yielding similar success. J Natl Cancer Inst. 2005; 97: 1030.
18. Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005; 6: 271-278.
19. Mahdavi A, Monk BJ. Vaccines against human papillomavirus and cervical cancer: promises and challenges. Oncologist. 2005; 10: 528-538.
20. Shaw AR. Human papillomavirus vaccines in development: if they're successful in clinical trials, how will they be implemented? Gynecol Oncol. 2005; 99: S246-S248.
21. Washam C. Targeting teens and adolescents for HPV vaccine could draw fire. J Natl Cancer Inst. 2005; 97: 1030-1031.
22. Coker AL, Bond S, Madeleine MM, Luchok K, Pirisi L. Psychosocial stress and cervical neoplasia risk. Psychosom Med. 2003; 65: 644-651.
23. Pereira DB, Antoni MH, Danielson A, et al. Life stress and cervical squamous intraepithelial lesions in women with human papillomavirus and human immunodeficiency virus. Psychosom Med. 2003; 65: 427-434.
24. Glaser R, Kiecolt-Glaser JK. Chronic stress modulates the virus-specific immune response to latent herpes simplex virus type 1. Annals Behav Med. 1997; 19: 78-82.
25. Kang DH, Fox C. Neuroendocrine and leukocyte responses and pulmonary function to acute stressors. Annals of Behav Med. 2000; 22: 276-285.
26. Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R. Psychoneuroimmunology: Psychological influences on immune function and health. J Consult Clin Psychol. 2002; 70: 537-547.
27. Kiecolt-Glaser JK, Robles TF, Heffner KL, Loving TJ, Glaser R. Psycho-oncology and cancer: psychoneuroimmunology and cancer. Ann Oncol. 2002; 13(Suppl 4): 165-169.
28. DeLongis A, Coyne J, Dakof G, Folkman S, Lazarus RS. Relationship of daily hassles, uplifts, and major life events to health status. Health Psychol. 1982; 1: 119-136.
29. Holmes TH, Rahe RH. The social readjustment rating scale. J Psychosom Res. 1967; 11: 213-218.
30. Cohen S, Kamarck TW, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983; 24: 385-396.
31. Cohen S, Doyle WJ, Skoner DP. Psychological stress, cytokine production, and severity of upper respiratory illness. Psychosom Med. 1999; 61: 175-180.
32. Cohen S, Hamrick N, Rodriguez MS, et al. Reactivity and vulnerability to stress-associated risk for upper respiratory illness. Psychosom Med. 2002; 64: 302-310.
33. Cohen S, Miller G, Rabin B. Psychological stress and antibody response to immunization: A critical review of the human literature. Psychosom Med. 2001; 63: 7-18.
34. Cohen S, Rabin BS. Psychologic stress, immunity, and cancer. J Natl Cancer Inst. 1998; 90: 3-4.
35. Cohen S, Tyrrell DA, Smith AP. Psychological stress and susceptibility to the common cold. N Engl J Med. 1991; 325: 606-612.
36. Luxton JC, Rowe AJ, Cridland JC, et al. Proliferative T cell responses to the human papillomavirus type 16 E7 protein in women with cervical dysplasia and cervical carcinoma and in healthy individuals. J Gen Virol. 1996; 77: 1585-1593.
37. Nakagawa M, Stites DP, Farhat S, et al. T-cell proliferative response to human papillomavirus type 16 peptides: Relationship to cervical intraepithelial neoplasia. Clin Diagn Lab Immunol. 1996; 3: 205-210.
38. Douglas SD, Hoffman PF, Borjeson J, Chessin LN. Studies on human peripheral blood lymphocytes in vitro. 3. Fine structural features of lymphocyte transformation by pokeweed mitogen. J Immunol. 1967; 98: 17-30.
39. Douglas SD, Kamin RM, Fudenberg HH. Human lymphocyte response to phytomitogens in vitro: normal, agammaglobulinemic and paraproteinemic individuals. J Immunol. 1969; 103: 1185-1195.
40. Borkowsky W, Stanley K, Douglas SD, et al. Immunologic response to combination nucleoside analogue plus protease inhibitor therapy in stable antiretroviral therapy-experienced human immunodeficiency virus-infected children. J Infect Dis. 2000; 182: 96-103.
41. Sarkar AK, Tortolero-Luna G, Follen M, Sastry KJ. Inverse correlation of cellular immune responses specific to synthetic peptides from the E6 and E7 oncoproteins of HPV-16 with recurrence of cervical intraepithelial neoplasia in a cross-sectional study. Gynecol Oncol. 2005; 99: S251-S261.
42. Fang CY, Miller SM, Mills M, et al. The effects of avoidance on cytotoxic/suppressor T cells in women with cervical lesions. Psychooncology. 2003; 12: 590-598.
43. Gill D, Bible J, Biswas C, et al. Proliferative T-cell responses to human papillomavirus type 16 E5 are decreased amongst women with high-grade neoplasia. J Gen Virol. 1998; 79: 1971-1976.
44. Steele JC, Mann CH, Rookes S, et al. T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia. Br J Cancer. 2005; 93: 248-259.
45. Brummer O, Hollwitz B, Bohmer G, Kuhnle H, Petry KU. Human papillomavirus-type persistence patterns predict the clinical outcome of cervical intraepithelial neoplasia. Gynecol Oncol. 2006; 102: 517-522.
46. Goodkin K, Antoni MH, Blaney PH. Stress and hopelessness in the promotion of cervical intraepithelial neoplasia to invasive squamous cell carcinoma of the cervix. J Psychosom Res. 1986; 30: 67-76.
47. Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R. Psychoneuroimmunology and psychosomatic medicine: Back to the future. Psychosom Med. 2002; 64: 15-28.
48. Paik IH, Toh KY, Lee C, Kim JJ, Lee SJ. Psychological stress may induce increased humoral and decreased cellular immunity. Behav Med. 2000; 26: 139-141.
49. Clerici M, Merola M, Ferrario E, et al. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst. 1997; 89: 245-250.
50. Peralta-Ramirez MI, Jimenez-Alonso J, Godoy-Garcia JF, Perez-Garcia M. The effects of daily stress and stressful life events on the clinical symptomatology of patients with lupus erythematosus. Psychosom Med. 2004; 66: 788-794.
51. Hamrick N, Cohen S, Rodriguez MS. Being popular can be healthy or unhealthy: stress, social network diversity, and incidence of upper respiratory infection. Health Psychol. 2002; 21: 294-298.
52. Folkman S. Personal control and stress and coping processes: A theoretical analysis. J Pers Soc Psychol. 1984; 46: 839-852.
53. Folkman S, Lazarus RS, Dunkel-Schetter C, De Longis A, Gruen RJ. Dynamics of a stressful encounter: Cognitive appraisal, coping, and encounter outcomes. J Pers Soc Psychol. 1986; 50: 992-1003.
54. Maier KJ, Waldstein SR, Synowski SJ. Relation of cognitive appraisal to cardiovascular reactivity, affect, and task engagement. Annals Behav Med. 2003; 26: 32-41.
55. Bontkes HJ, de Gruijl TD, Walboomers JM, et al. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16. J Gen Virol. 1999; 80(Pt 2): 409-417.